Medical Affairs & Commercial Collaboration For Launch Success

How To Strengthen Launch Strategies With Medical Affairs & Commercial Collaboration

In today’s fast-paced market, success isn’t just about moving fast; it’s about moving together. Launch excellence depends on early alignment across medical affairs, commercial, market access and compliance, with an agile mindset that carries development through commercialization. This webinar explores how teams can connect early and often to make smarter decisions, stay compliant and improve patient outcomes.

As therapies grow more complex, from precision medicine and rare disease to cell and gene therapy, leaner teams and tighter timelines make cross-functional collaboration non-negotiable. When teams connect early and often, they make smarter decisions, stay compliant, and ultimately help improve patient outcomes.

The featured panel of compliance, medical, and commercial leaders share how alignment drives innovative and compliant launch strategies. Through real-world examples, attendees see how shared, AI-driven insights can help both medical and commercial teams understand real-world treatment patterns, surface the right evidence early, anticipate HCP needs, and coordinate actions that build trust with HCPs, patients, and caregivers.

The webinar also explores when and how outsourced, integrated medical and commercial support can add specialized expertise, helping teams address market access challenges and increasing payer scrutiny with a consistent, compliant approach.

Watch now to learn how strategies focused on medical affairs and commercial alignment can help support compliant customer engagement and improve launch readiness.

 

Watch Now

 

Featured Speakers:

  • Laura Heyduk, Head of Global Compliance, KalVista Pharmaceuticals
  • Kirsten Duncan, PharmD, Vice President, Head of Medical Affairs, Nuvalent
  • Brian O’Donnell, President, Commercial, Amplity

 

Watch Now

 

We can help you level up your launches, from pre-launch to in market. Learn more about our commercial and medical affairs teams offerings.

 

 

PUBLISHED

June 30, 2026
Read Next
June 23, 2026
May 26, 2026
January 16, 2026
Commercial